Page:Interim Staff Report on Investigation into Risky MPXV Experiment at the National Institute of Allergy and Infectious Diseases.pdf/39



The Honorable Cathy McMorris Rodgers Chair Committee on Energy and Commerce U.S. House of Representatives Washington, D.C. 20515

Dear Chair Rodgers:

Thank you for your March 30, 2023, and May 30, 2023, letters regarding research on mpox, formerly known as monkeypox, at the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The enclosed document is a letter from Dr. Bernard Moss, NIH Distinguished Investigator at the Laboratory of Viral Diseases at NIAID.

If you or your staff have any questions, please feel free to contact the Office of the Assistant Secretary for Legislation at (202) 690-7627.

Enclosure